384 related articles for article (PubMed ID: 21554899)
1. Promise of resveratrol for easing status epilepticus and epilepsy.
Shetty AK
Pharmacol Ther; 2011 Sep; 131(3):269-86. PubMed ID: 21554899
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol Treatment after Status Epilepticus Restrains Neurodegeneration and Abnormal Neurogenesis with Suppression of Oxidative Stress and Inflammation.
Mishra V; Shuai B; Kodali M; Shetty GA; Hattiangady B; Rao X; Shetty AK
Sci Rep; 2015 Dec; 5():17807. PubMed ID: 26639668
[TBL] [Abstract][Full Text] [Related]
3. Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities.
Upadhya D; Castro OW; Upadhya R; Shetty AK
Mol Neurobiol; 2018 Aug; 55(8):6956-6964. PubMed ID: 29372545
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol for Easing Status Epilepticus Induced Brain Injury, Inflammation, Epileptogenesis, and Cognitive and Memory Dysfunction-Are We There Yet?
Castro OW; Upadhya D; Kodali M; Shetty AK
Front Neurol; 2017; 8():603. PubMed ID: 29180982
[TBL] [Abstract][Full Text] [Related]
5. Trans-resveratrol: a magical elixir of eternal youth?
Orallo F
Curr Med Chem; 2008; 15(19):1887-98. PubMed ID: 18691046
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppressed seizures by attenuating IL-1β, IL1-Ra, IL-6, and TNF-α in the hippocampus and cortex of kindled mice.
Hoda U; Agarwal NB; Vohora D; Parvez S; Raisuddin S
Nutr Neurosci; 2017 Nov; 20(9):497-504. PubMed ID: 27256583
[TBL] [Abstract][Full Text] [Related]
7. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
Löscher W
Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
[TBL] [Abstract][Full Text] [Related]
8. Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats.
Di Maio R; Cannon JR; Greenamyre JT
Neurobiol Dis; 2015 Jan; 73():356-65. PubMed ID: 25447228
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol plays important role in protective mechanisms in renal disease--mini-review.
Albertoni G; Schor N
J Bras Nefrol; 2015; 37(1):106-14. PubMed ID: 25923757
[TBL] [Abstract][Full Text] [Related]
10. Concise Review: Prospects of Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells for Treating Status Epilepticus and Chronic Epilepsy.
Agadi S; Shetty AK
Stem Cells; 2015 Jul; 33(7):2093-103. PubMed ID: 25851047
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol in epilepsy: preventive or treatment opportunities?
Pallàs M; Ortuño-Sahagún D; Andrés-Benito P; Ponce-Regalado MD; Rojas-Mayorquín AE
Front Biosci (Landmark Ed); 2014 Jun; 19(7):1057-64. PubMed ID: 24896336
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.
Patra PH; Barker-Haliski M; White HS; Whalley BJ; Glyn S; Sandhu H; Jones N; Bazelot M; Williams CM; McNeish AJ
Epilepsia; 2019 Feb; 60(2):303-314. PubMed ID: 30588604
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol-loaded nanoemulsion prevents cognitive decline after abdominal surgery in aged rats.
Locatelli FM; Kawano T; Iwata H; Aoyama B; Eguchi S; Nishigaki A; Yamanaka D; Tateiwa H; Shigematsu-Locatelli M; Yokoyama M
J Pharmacol Sci; 2018 Aug; 137(4):395-402. PubMed ID: 30196020
[TBL] [Abstract][Full Text] [Related]
14. Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model.
Sinka L; Abraira L; Imbach LL; Zieglgänsberger D; Santamarina E; Álvarez-Sabín J; Ferreira-Atuesta C; Katan M; Scherrer N; Bicciato G; Terziev R; Simmen C; Schubert KM; Elshahabi A; Baumann CR; Döhler N; Erdélyi-Canavese B; Felbecker A; Siebel P; Winklehner M; von Oertzen TJ; Wagner JN; Gigli GL; Serafini A; Nilo A; Janes F; Merlino G; Valente M; Zafra-Sierra MP; Bayona-Ortiz H; Conrad J; Evers S; Lochner P; Roell F; Brigo F; Bentes C; Peralta AR; Pinho E Melo T; Keezer MR; Duncan JS; Sander JW; Tettenborn B; Koepp MJ; Galovic M
JAMA Neurol; 2023 Jun; 80(6):605-613. PubMed ID: 37036702
[TBL] [Abstract][Full Text] [Related]
15. Prospects of levetiracetam as a neuroprotective drug against status epilepticus, traumatic brain injury, and stroke.
Shetty AK
Front Neurol; 2013 Nov; 4():172. PubMed ID: 24204362
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant Effect of Turmeric and Resveratrol in Lithium/Pilocarpine-Induced Status Epilepticus in Wistar Rats.
Zamora-Bello I; Rivadeneyra-Domínguez E; Rodríguez-Landa JF
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744955
[TBL] [Abstract][Full Text] [Related]
17. Essential role of ER-alpha-dependent NO production in resveratrol-mediated inhibition of restenosis.
Khandelwal AR; Hebert VY; Dugas TR
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1451-8. PubMed ID: 20709862
[TBL] [Abstract][Full Text] [Related]
18. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.
White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M
Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444
[TBL] [Abstract][Full Text] [Related]
19. Epilepsy Emergencies.
Hantus S
Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):173-90. PubMed ID: 26844736
[TBL] [Abstract][Full Text] [Related]
20. N-Formyl-Methionyl-Leucyl-Phenylalanine Plays a Neuroprotective and Anticonvulsant Role in Status Epilepticus Model.
de Melo IS; Sabino-Silva R; Costa MA; Vaz ER; Anselmo-E-Silva CI; de Paula Soares Mendonça T; Oliveira KB; de Souza FMA; Dos Santos YMO; Pacheco ALD; Freitas-Santos J; Caixeta DC; Goulart LR; de Castro OW
Cell Mol Neurobiol; 2023 Nov; 43(8):4231-4244. PubMed ID: 37742326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
